Medicare Advantage COVID Treatment Act
USA116th CongressHR-6640| House
| Updated: 4/28/2020
Debbie Mucarsel-Powell
Democratic Representative
Florida
Cosponsors (11)
Gilbert Ray Cisneros (Democratic)Sheila Jackson Lee (Democratic)Derek Kilmer (Democratic)Frederica S. Wilson (Democratic)Steve Cohen (Democratic)Joseph D. Morelle (Democratic)Jahana Hayes (Democratic)Bonnie Watson Coleman (Democratic)Cynthia Axne (Democratic)Ron Kind (Democratic)Gwen Moore (Democratic)
Ways and Means Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Medicare Advantage COVID Treatment Act This bill requires Medicare Advantage (MA) plans to cover specified treatment services relating to COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency declared on January 31, 2020. The CMS must reimburse MA plans for cost-sharing amounts that would otherwise have been received, in accordance with a specified timeline. MA plans are also prohibited from instituting prior authorization or other utilization management requirements with respect to coverage of specified critical treatment services (e.g., ventilator services and intensive care unit services).
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Health
Cardiovascular and respiratory healthEmergency medical services and trauma careHealth care costs and insuranceHealth care coverage and accessHospital careInfectious and parasitic diseasesMedicare
Medicare Advantage COVID Treatment Act
USA116th CongressHR-6640| House
| Updated: 4/28/2020
Medicare Advantage COVID Treatment Act This bill requires Medicare Advantage (MA) plans to cover specified treatment services relating to COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency declared on January 31, 2020. The CMS must reimburse MA plans for cost-sharing amounts that would otherwise have been received, in accordance with a specified timeline. MA plans are also prohibited from instituting prior authorization or other utilization management requirements with respect to coverage of specified critical treatment services (e.g., ventilator services and intensive care unit services).
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Debbie Mucarsel-Powell
Democratic Representative
Florida
Cosponsors (11)
Gilbert Ray Cisneros (Democratic)Sheila Jackson Lee (Democratic)Derek Kilmer (Democratic)Frederica S. Wilson (Democratic)Steve Cohen (Democratic)Joseph D. Morelle (Democratic)Jahana Hayes (Democratic)Bonnie Watson Coleman (Democratic)Cynthia Axne (Democratic)Ron Kind (Democratic)Gwen Moore (Democratic)
Ways and Means Committee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Cardiovascular and respiratory healthEmergency medical services and trauma careHealth care costs and insuranceHealth care coverage and accessHospital careInfectious and parasitic diseasesMedicare